Cellint Bio

Company Overview

Snapshot

Founded in January 2025 by Matan Hershko and Linur Yeter, Cellint Bio operates with 1–10 employees. The company has secured funding across one round from four investors, with Jibe Ventures and Inovia Capital among them. In April 2026, Cellint Bio completed a Seed funding round.

Business overview

Cellint Bio develops a fully automated cell-culture R&D platform designed for biological researchers conducting cell-based experiments. The system integrates hardware, mechanics, software, and AI to function within a standard incubator, enabling remote monitoring of cell-culture workflows, data visualization, and the generation of predictive insights. This technology aims to minimize manual handling, reduce contamination risks, and decrease execution errors in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Drugs Discovery & Development.

Company Intelligence Q&A

When was Cellint Bio founded?

Cellint Bio was founded in January 2025 by co-founders Matan Hershko and Linur Yeter.

What is Cellint Bio's primary focus?

Cellint Bio focuses on providing a fully automated cell-culture R&D platform for biological researchers, combining hardware, mechanics, software, and AI to streamline cell-based experiments.

Which investors participated in Cellint Bio's Seed funding round?

In April 2026, Cellint Bio completed a Seed funding round with participation from investors including.

What problem does Cellint Bio's platform address?

Cellint Bio's platform addresses challenges in cell-culture R&D by automating workflows, enabling remote monitoring, and providing predictive insights to reduce manual handling, contamination, and errors.

What is the employee count for Cellint Bio?

Cellint Bio currently has 1–10 employees.